Pfizer 5 XNB Pill - red three-sided, 8mm
Generic Name: axitinib
Pill with imprint Pfizer 5 XNB is Red, Three-sided and has been identified as Inlyta 5 mg. It is supplied by Pfizer Inc.
Inlyta is used in the treatment of Renal Cell Carcinoma and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Inlyta 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer 5 XNB
Inlyta
- Generic Name
- axitinib
- Imprint
- Pfizer 5 XNB
- Strength
- 5 mg
- Color
- Red
- Size
- 8.00 mm
- Shape
- Three-sided
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors, VEGF/VEGFR inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-0151
- Inactive Ingredients
-
microcrystalline cellulose,
lactose monohydrate,
croscarmellose sodium,
magnesium stearate,
titanium dioxide,
triacetin,
ferric oxide red,
hypromellose 2910 (15000 mPa.s)
Note: Inactive ingredients may vary.
More about Inlyta (axitinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
